GT BIOPHARMA, INC. Share-based Payment Arrangement, Expense
GT BIOPHARMA, INC. (GTBP) reported Share-based Payment Arrangement, Expense of $42.00 thousand for the 12-month period ending 2016-12-31, per its 10-K/A filed 2018-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-02-28
- GT BIOPHARMA, INC. share-based payment arrangement, expense for the quarter ending 2015-12-31 was -$1.60M, a 1087.04% decline year-over-year.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for the quarter ending 2015-03-31 was $163.00K.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for the quarter ending 2014-12-31 was $162.00K, a 78.51% decline year-over-year.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for the quarter ending 2014-09-30 was $0.00.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for fiscal 2016 was $42.00K, a 81.00% decline from fiscal 2015.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for fiscal 2015 was $221.00K, a 36.42% increase from fiscal 2014.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for fiscal 2014 was $162.00K, a 82.56% decline from fiscal 2013.
- GT BIOPHARMA, INC. share-based payment arrangement, expense for fiscal 2013 was $929.00K, a 206.60% increase from fiscal 2012.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2016-12-31 | $42.00K 10-K/A · filed 2018-02-28 | |||||
| 2015-12-31 | -$1.60M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $221.00K 10-K/A · filed 2018-02-28 | ||||
| 2015-09-30 | $1.82M 10-Q · filed 2015-11-13 | |||||
| 2015-03-31 | $163.00K 10-Q · filed 2015-05-14 | $325.00K derived: sum of 2 quarters · filed 2018-02-28 | $325.00K derived: sum of 3 quarters · filed 2018-02-28 | $325.00K derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2014-12-31 | $162.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $162.00K derived: sum of 2 quarters · filed 2018-02-28 | $162.00K derived: sum of 3 quarters · filed 2018-02-28 | $162.00K 10-K/A · filed 2018-02-28 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | $754.00K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-08 | $0.00 10-Q · filed 2015-01-08 | $754.00K derived: sum of 3 quarters · filed 2015-05-14 | $754.00K derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $754.00K derived: sum of 2 quarters · filed 2015-05-14 | $754.00K derived: sum of 3 quarters · filed 2015-05-14 | $754.00K derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2013-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $754.00K derived: sum of 2 quarters · filed 2015-03-31 | $754.00K derived: sum of 3 quarters · filed 2015-03-31 | $929.00K 10-K · filed 2015-03-31 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-01-08 | $0.00 derived: sum of 2 quarters · filed 2015-01-08 | $175.00K 10-Q · filed 2015-01-08 | -$221.00K derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-08 | $175.00K 10-Q · filed 2015-01-08 | -$221.00K derived: sum of 3 quarters · filed 2015-01-08 | $57.00K derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2013-03-31 | $175.00K 10-Q · filed 2015-01-08 | $176.00K 10-Q · filed 2014-12-10 | -$221.00K derived: sum of 2 quarters · filed 2015-01-08 | $57.00K derived: sum of 3 quarters · filed 2015-01-08 | $335.00K derived: sum of 4 quarters · filed 2015-01-08 | |
| 2012-12-31 | -$396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | -$118.00K derived: sum of 2 quarters · filed 2015-01-08 | $160.00K derived: sum of 3 quarters · filed 2015-01-08 | $303.00K 10-K · filed 2015-01-08 | $929.00K 10-K · filed 2014-11-18 | |
| 2012-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-12-17 | $556.00K derived: sum of 2 quarters · filed 2014-12-17 | $699.00K 10-Q · filed 2014-12-17 | $695.00K derived: sum of 4 quarters · filed 2014-12-17 | ||
| 2012-06-30 | $278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-12 | $421.00K 10-Q · filed 2014-12-12 | $417.00K derived: sum of 3 quarters · filed 2014-12-12 | |||
| 2012-03-31 | $143.00K 10-Q · filed 2014-12-10 | $139.00K derived: sum of 2 quarters · filed 2014-12-10 | ||||
| 2011-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $303.00K 10-K · filed 2014-11-18 | ||||
| 2011-09-30 | $307.00K 10-Q · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |